Cargando…
Statin Type and Cancer Outcomes in Patients with Diabetes Type 2 and Solid Tumors
OBJECTIVE: Type 2 diabetes mellitus (T2DM) affects 10% of Americans and is associated with an increased incidence of cancer. Statins are first-line cholesterol-lowering medications in the treatment of hyperlipidemia. Several studies have demonstrated a relationship between statin use and reduced can...
Autores principales: | Ceacareanu, Alice C., Jolly, Shanria D., Nimako, George K., Wintrob, Zachary A. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259595/ https://www.ncbi.nlm.nih.gov/pubmed/34295853 http://dx.doi.org/10.4103/jrpp.JRPP_21_3 |
Ejemplares similares
-
Missing the Benefit of Metformin in Acute Myeloid Leukemia: A Problem of Contrast?
por: Ceacareanu, Alice C., et al.
Publicado: (2017) -
TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017) -
56600 Statin use and medical expenditure in patients with Parkinson’s disease
por: Lo Piccolo, Anthony J., et al.
Publicado: (2021) -
Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017) -
Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)